CD74hi TAMs decrease during OSCCprogression and are associated with patient prognosis. Loss of CD74 impairs antigen presentation andsuppresses T cell activation. Tumor-derived lactateinhibits CD74 transcription via C/EBPα acetylation.
Wang et al. (Sun,) studied this question.